253 related articles for article (PubMed ID: 16499563)
21. A novel series of 2,5-substituted tryptamine derivatives as vascular 5HT1B/1D receptor antagonists.
Moloney GP; Robertson AD; Martin GR; MacLennan S; Mathews N; Dodsworth S; Sang PY; Knight C; Glen R
J Med Chem; 1997 Jul; 40(15):2347-62. PubMed ID: 9240350
[TBL] [Abstract][Full Text] [Related]
22. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
Imbesi M; Uz T; Manev H
Neuroscience; 2008 Sep; 155(4):1160-4. PubMed ID: 18664376
[TBL] [Abstract][Full Text] [Related]
23. The oxidation products of melatonin derivatives exhibit acetylcholinesterase and butyrylcholinesterase inhibitory activity.
Siwicka A; Moleda Z; Wojtasiewicz K; Zawadzka A; Maurin JK; Panasiewicz M; Pacuszka T; Czarnocki Z
J Pineal Res; 2008 Aug; 45(1):40-9. PubMed ID: 18284552
[TBL] [Abstract][Full Text] [Related]
24. Tryptamine-derived alkaloids from Annonaceae exerting neurotrophin-like properties on primary dopaminergic neurons.
Schmidt F; Le Douaron G; Champy P; Amar M; Séon-Méniel B; Raisman-Vozari R; Figadère B
Bioorg Med Chem; 2010 Jul; 18(14):5103-13. PubMed ID: 20579892
[TBL] [Abstract][Full Text] [Related]
25. Melatonin receptor ligands: synthesis of new melatonin derivatives and comprehensive comparative molecular field analysis (CoMFA) study.
Mor M; Rivara S; Silva C; Bordi F; Plazzi PV; Spadoni G; Diamantini G; Balsamini C; Tarzia G; Fraschini F; Lucini V; Nonno R; Stankov BM
J Med Chem; 1998 Sep; 41(20):3831-44. PubMed ID: 9748358
[TBL] [Abstract][Full Text] [Related]
26. Cytoprotective effect of caffeic acid phenethyl ester (CAPE) and catechol ring-fluorinated CAPE derivatives against menadione-induced oxidative stress in human endothelial cells.
Wang X; Stavchansky S; Bowman PD; Kerwin SM
Bioorg Med Chem; 2006 Jul; 14(14):4879-87. PubMed ID: 16580214
[TBL] [Abstract][Full Text] [Related]
27. Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.
Tsotinis A; Vlachou M; Papahatjis DP; Calogeropoulou T; Nikas SP; Garratt PJ; Piccio V; Vonhoff S; Davidson K; Teh MT; Sugden D
J Med Chem; 2006 Jun; 49(12):3509-19. PubMed ID: 16759094
[TBL] [Abstract][Full Text] [Related]
28. Reassessing the melatonin pharmacophore--enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue.
Rivara S; Diamantini G; Di Giacomo B; Lamba D; Gatti G; Lucini V; Pannacci M; Mor M; Spadoni G; Tarzia G
Bioorg Med Chem; 2006 May; 14(10):3383-91. PubMed ID: 16431121
[TBL] [Abstract][Full Text] [Related]
29. Antioxidant and neuroprotective properties of N-arachidonoyldopamine.
Bobrov MY; Lizhin AA; Andrianova EL; Gretskaya NM; Frumkina LE; Khaspekov LG; Bezuglov VV
Neurosci Lett; 2008 Jan; 431(1):6-11. PubMed ID: 18069125
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and antioxidant properties of substituted 2-phenyl-1H-indoles.
Karaaslan C; Kadri H; Coban T; Suzen S; Westwell AD
Bioorg Med Chem Lett; 2013 May; 23(9):2671-4. PubMed ID: 23540647
[TBL] [Abstract][Full Text] [Related]
31. Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression.
Fernandez-Gomez FJ; Pastor MD; Garcia-Martinez EM; Melero-Fernandez de Mera R; Gou-Fabregas M; Gomez-Lazaro M; Calvo S; Soler RM; Galindo MF; Jordán J
Neurobiol Dis; 2006 Nov; 24(2):296-307. PubMed ID: 16978869
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and pharmacological evaluation of 1,2,3,4-tetrahydropyrazino[1,2-a]indole and 2-[(phenylmethylamino)methyl]-1H-indole analogues as novel melatoninergic ligands.
Markl C; Attia MI; Julius J; Sethi S; Witt-Enderby PA; Zlotos DP
Bioorg Med Chem; 2009 Jul; 17(13):4583-94. PubMed ID: 19473848
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists: lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores.
Teh MT; Sugden D
Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):522-8. PubMed ID: 9840420
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of 1-substituted 3-(chloromethyl)-6-aminoindoline (6-amino-seco-CI) DNA minor groove alkylating agents and structure-activity relationships for their cytotoxicity.
Milbank JB; Tercel M; Atwell GJ; Wilson WR; Hogg A; Denny WA
J Med Chem; 1999 Feb; 42(4):649-58. PubMed ID: 10052972
[TBL] [Abstract][Full Text] [Related]
35. Novel indole-based melatonin analogues: Evaluation of antioxidant activity and protective effect against amyloid β-induced damage.
Gurer-Orhan H; Karaaslan C; Ozcan S; Firuzi O; Tavakkoli M; Saso L; Suzen S
Bioorg Med Chem; 2016 Apr; 24(8):1658-64. PubMed ID: 26970662
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and comparison of antioxidant properties of indole-based melatonin analogue indole amino Acid derivatives.
Suzen S; Cihaner SS; Coban T
Chem Biol Drug Des; 2012 Jan; 79(1):76-83. PubMed ID: 21883955
[TBL] [Abstract][Full Text] [Related]
37. Novel 2-substituted nitronyl nitroxides as free radical scavengers: synthesis, biological evaluation and structure-activity relationship.
Wu Y; Bi L; Bi W; Li Z; Zhao M; Wang C; Ju J; Peng S
Bioorg Med Chem; 2006 Aug; 14(16):5711-20. PubMed ID: 16650996
[TBL] [Abstract][Full Text] [Related]
38. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT).
Konturek SJ; Konturek PC; Brzozowska I; Pawlik M; Sliwowski Z; Cześnikiewicz-Guzik M; Kwiecień S; Brzozowski T; Bubenik GA; Pawlik WW
J Physiol Pharmacol; 2007 Sep; 58(3):381-405. PubMed ID: 17928638
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antioxidant activity evaluation of new 7-aryl or 7-heteroarylamino-2,3-dimethylbenzo[b]thiophenes obtained by Buchwald-Hartwig C-N cross-coupling.
Queiroz MJ; Ferreira IC; Calhelha RC; Estevinho LM
Bioorg Med Chem; 2007 Feb; 15(4):1788-94. PubMed ID: 17166720
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and melatoninergic potency of new N-acyl 8,9-dihydro-4-methoxy-7H-2-benzo[de]quinolinalkanamines.
Tsotinis A; Eleutheriades A; Hough KA; Davidson K; Sugden D
Bioorg Chem; 2007 Apr; 35(2):189-204. PubMed ID: 17223160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
